ArticleMethodsX2018
Study of particle number size distributions at Azadi terminal in Tehran, comparing high-traffic and no traffic area.
Article in MethodsX, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Article
- Article
- The effect of PMEnvironmental science and pollution research international · 2022Article
- Potential cytotoxicity of PM2.5-bound PAHs and toxic metals collected from areas with different traffic densities on human lung epithelial cells (A549).Journal of environmental health science & engineering · 2021Article
- Spatial distribution and health risk of exposure to BTEX in urban area: a comparison study of different land-use types and traffic volumes.Environmental geochemistry and health · 2021Article
- Airborne particulate matter in Tehran's ambient air.Journal of environmental health science & engineering · 2021Review
- Characterization, possible sources and health risk assessment of PM2.5-bound Heavy Metals in the most industrial city of Iran.Journal of environmental health science & engineering · 2021Article
- Health risk assessment and source apportionment of heavy metals in atmospheric dustfall in a city of Khuzestan Province, Iran.Journal of environmental health science & engineering · 2021Article
- Monitoring of airborne asbestos fibers in an urban ambient air of Mashhad City, Iran: levels, spatial distribution and seasonal variations.Journal of environmental health science & engineering · 2020Article
- Assessment of common plant parameters as biomarkers of air pollution.Environmental monitoring and assessment · 2019Article
- Investigation of thermal exposure in traditional neyshabur bakeries using heat strain and physiological indices.MethodsX · 2019Article
- The investigation of type and concentration of bio-aerosols in the air of surgical rooms: A case study in Shariati hospital, Karaj.MethodsX · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vehicle traffic is known as the anthropogenic aerosol source in megacities. Exposure to ambient air pollution, especially particulate matter has become the most environmental risk factor. The main aim of this study is to determine the particle number and their size distribution in Tehran at Azadi terminal (located in the West of Tehran), crossing of Nawab and Azadi streets the area with high traffic, and campus of Tehran University as an area without traffic. Particle size distribution (0.3-1 μm) was measured using a Grimm Environmental Dust Monitor and was conducted in two seasons, hot and cold (summer 2016 and winter 2016). The measurement was performed twice per month. Although the average number of particles at Azadi Terminal was more than the other two locations in both seasons but it was not significant) p > 0.05). The average number of particles larger than 0.3 μm was 286.72 ± 129.55 and 183.61 ± 86.79 cm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.